Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...
Russell Brand Shuts Down Mental Health And Addiction Charity Following Sexual Assault Allegations
The British presenter turned online guru has moved to the US following allegations of sexual abuse, which he denies.
Red dye No. 3 has been banned, but what about other artificial food dyes?
Health officials banned the artificial food color known as Red 3 from the U.S. food supply in January, citing a federal ...